UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Population pharmacokinetics of recombinant factor VIII: the relationships of pharmacokinetics to age and body weight

Blood, 2012-01, Vol.119 (2), p.612-618

2012

Volltextzugriff (PDF)

Prediction of cytochrome P450-mediated hepatic drug clearance in neonates, infants and children : How accurate are available scaling methods?

Clinical pharmacokinetics, 2006, Vol.45 (1), p.1-11

Bjorkman, Sven

2006

Volltextzugriff (PDF)

Oxymorphone Active Uptake at the Blood–Brain Barrier and Population Modeling of its Pharmacokinetic–Pharmacodynamic Relationship

Journal of pharmaceutical sciences, 2013-09, Vol.102 (9), p.3320-3331

2013

Volltextzugriff (PDF)

Methods for individualising factor VIII dosing in prophylaxis

European journal of haematology, 2014-08, Vol.93 (s76), p.16-20

2014

Volltextzugriff (PDF)

Diphenhydramine Active Uptake at the Blood–Brain Barrier and Its Interaction with Oxycodone in vitro and in Vivo

Journal of pharmaceutical sciences, 2011-09, Vol.100 (9), p.3912-3923

2011

Volltextzugriff (PDF)

Population pharmacokinetics of plasma-derived factor IX in adult patients with haemophilia B: implications for dosing in prophylaxis

European journal of clinical pharmacology, 2012-06, Vol.68 (6), p.969-977

2012

Volltextzugriff (PDF)

A Whole‐Body Physiologically Based Pharmacokinetic Model for Colistin and Colistin Methanesulfonate in Rat

Basic & clinical pharmacology & toxicology, 2018-10, Vol.123 (4), p.407-422

2018

Volltextzugriff (PDF)

Clinical pharmacology of thalidomide

European journal of clinical pharmacology, 2001-08, Vol.57 (5), p.365-376

2001

Volltextzugriff (PDF)

Pharmacokinetics and dose requirements of factor VIII over the age range 3-74 years

European journal of clinical pharmacology, 2009-06, Vol.65 (10), p.989-998

2009

Volltextzugriff (PDF)

Enhanced Brain Delivery of the Opioid Peptide DAMGO in Glutathione PEGylated Liposomes: A Microdialysis Study

Molecular pharmaceutics, 2013-05, Vol.10 (5), p.1533-1541

2013

Volltextzugriff (PDF)

Cyclooxygenase inhibition causes marked impairment of renal function in elderly subjects treated with diuretics and ACE-inhibitors

European journal of heart failure, 2005-10, Vol.7 (6), p.1049-1056

2005

Volltextzugriff (PDF)

Ultralong peripheral nerve block by lidocaine:prilocaine 1:1 mixture in a lipid depot formulation: comparison of in vitro, in vivo, and effect kinetics

Anesthesiology (Philadelphia), 2006-01, Vol.104 (1), p.110

2006

Volltextzugriff (PDF)

Local anesthetics in lipid-depot formulations--neurotoxicity in relation to duration of effect in a rat model

Regional anesthesia and pain medicine, 2006-09, Vol.31 (5), p.401-408

2006

Volltextzugriff (PDF)

The “inverted cup” — A novel in vitro release technique for drugs in lipid formulations

Journal of controlled release, 2006-06, Vol.113 (1), p.80-88

2006

Volltextzugriff (PDF)

Prediction of drug disposition in infants and children by means of physiologically based pharmacokinetic (PBPK) modelling: theophylline and midazolam as model drugs

British journal of clinical pharmacology, 2005-06, Vol.59 (6), p.691-704

Björkman, Sven

2005

Volltextzugriff (PDF)

Computer simulation of the effects of alterations in blood flows and body composition on thiopental pharmacokinetics in humans

Anesthesiology (Philadelphia), 1997-10, Vol.87 (4), p.884-899

1997

Volltextzugriff (PDF)

In vivo recovery of factor VIII and factor IX: intra- and interindividual variance in a clinical setting

Haemophilia : the official journal of the World Federation of Hemophilia, 2007-01, Vol.13 (1), p.2-8

2007

Volltextzugriff (PDF)

Application of physiologic models to predict the influence of changes in body composition and blood flows on the pharmacokinetics of fentanyl and alfentanil in patients

Anesthesiology (Philadelphia), 1998-03, Vol.88 (3), p.657-667

1998

Volltextzugriff (PDF)

A placebo‐controlled study of retinal blood flow changes by pentoxifylline and metabolites in humans

British journal of clinical pharmacology, 2006-02, Vol.61 (2), p.138-147

2006

Volltextzugriff (PDF)

Reduction and lumping of physiologically based pharmacokinetic models: Prediction of the disposition of fentanyl and pethidine in humans by successively simplified models

Journal of pharmacokinetics and pharmacodynamics, 2003-08, Vol.30 (4), p.285-307

BJÖRKMAN, Sven

2003

Volltextzugriff (PDF)

In-vitro release of bupivacaine from injectable lipid formulations investigated by a single drop technique - relation to duration of action in-vivo

Journal of pharmacy and pharmacology, 2002-06, Vol.54 (6), p.747-755

2002

Volltextzugriff (PDF)

Population pharmacokinetics of recombinant factor IX: implications for dose tailoring

Haemophilia : the official journal of the World Federation of Hemophilia, 2013-09, Vol.19 (5), p.753-757

Bjorkman, S

2013

Volltextzugriff (PDF)

Limited blood sampling for pharmacokinetic dose tailoring of FVIII in the prophylactic treatment of haemophilia A

Haemophilia : the official journal of the World Federation of Hemophilia, 2010-07, Vol.16 (4), p.597-605

BJÖRKMAN, S.

2010

Volltextzugriff (PDF)

Effects of pentoxifylline and its metabolites on platelet aggregation in whole blood from healthy humans

European journal of pharmacology, 2008-03, Vol.581 (3), p.290-295

2008

Volltextzugriff (PDF)

Implications of coagulation factor VIII and IX pharmacokinetics in the prophylactic treatment of haemophilia

Haemophilia : the official journal of the World Federation of Hemophilia, 2011-01, Vol.17 (1), p.2-10

2011

Volltextzugriff (PDF)

1 – 25 von 245

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(174)
Mit Volltextzugriff
(208)

Publikationsform

Artikel
(202)
Buchkapitel
(20)
Reviews
(20)
Bücher
(2)
Berichte
(1)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Population pharmacokinetics of recombinant factor VIII: the relationships of pharmacokinetics to age and body weight

Prediction of cytochrome P450-mediated hepatic drug clearance in neonates, infants and children : How accurate are available scaling methods?

Oxymorphone Active Uptake at the Blood–Brain Barrier and Population Modeling of its Pharmacokinetic–Pharmacodynamic Relationship

Methods for individualising factor VIII dosing in prophylaxis

Diphenhydramine Active Uptake at the Blood–Brain Barrier and Its Interaction with Oxycodone in vitro and in Vivo

Population pharmacokinetics of plasma-derived factor IX in adult patients with haemophilia B: implications for dosing in prophylaxis

A Whole‐Body Physiologically Based Pharmacokinetic Model for Colistin and Colistin Methanesulfonate in Rat

Clinical pharmacology of thalidomide

Pharmacokinetics and dose requirements of factor VIII over the age range 3-74 years

Enhanced Brain Delivery of the Opioid Peptide DAMGO in Glutathione PEGylated Liposomes: A Microdialysis Study

Cyclooxygenase inhibition causes marked impairment of renal function in elderly subjects treated with diuretics and ACE-inhibitors

Ultralong peripheral nerve block by lidocaine:prilocaine 1:1 mixture in a lipid depot formulation: comparison of in vitro, in vivo, and effect kinetics

Local anesthetics in lipid-depot formulations--neurotoxicity in relation to duration of effect in a rat model

The “inverted cup” — A novel in vitro release technique for drugs in lipid formulations

Prediction of drug disposition in infants and children by means of physiologically based pharmacokinetic (PBPK) modelling: theophylline and midazolam as model drugs

Computer simulation of the effects of alterations in blood flows and body composition on thiopental pharmacokinetics in humans

In vivo recovery of factor VIII and factor IX: intra- and interindividual variance in a clinical setting

Application of physiologic models to predict the influence of changes in body composition and blood flows on the pharmacokinetics of fentanyl and alfentanil in patients

A placebo‐controlled study of retinal blood flow changes by pentoxifylline and metabolites in humans

Reduction and lumping of physiologically based pharmacokinetic models: Prediction of the disposition of fentanyl and pethidine in humans by successively simplified models

In-vitro release of bupivacaine from injectable lipid formulations investigated by a single drop technique - relation to duration of action in-vivo

Population pharmacokinetics of recombinant factor IX: implications for dose tailoring

Limited blood sampling for pharmacokinetic dose tailoring of FVIII in the prophylactic treatment of haemophilia A

Effects of pentoxifylline and its metabolites on platelet aggregation in whole blood from healthy humans

Implications of coagulation factor VIII and IX pharmacokinetics in the prophylactic treatment of haemophilia

Suchergebnisse filtern